Component
Gamma-carboxylated matrix Gla protein
Gamma-carboxylated matrix Gla protein. Species, exposure and limitations are retained in each linked claim.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
MGP Gla residues and Pro64 contributed to BMP4 binding and inhibition; only BMP4-binding-competent variants prevented osteogenic differentiation and calcification.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/k2-research/18369157.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "34c7571f9f3a564647e458dc072113e807c277eaf5f542d6f3ab2e45f71ea5a4", "start_char": 0, "end_char": 1696, "text_sha256": "34c7571f9f3a564647e458dc072113e807c277eaf5f542d6f3ab2e45f71ea5a4"}
- experimental_model
- Site-directed mutants, calcium assays and BMP reporters
- exposure
- Gla and Pro64 alterations, calcium chelation and warfarin
- limitations
- Binding and calcification in experimental systems; systemic calcium should not be equated with a single binding-site measurement.
- nutrient_topic
- Vitamin K2 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin K2 / menaquinone family
- organism
- MGP expression systems and calcifying vascular cells
- plain_language
- A calcium-binding protein also controls a signal that can change cell behavior.
- primary_references
- [k2-p18369157] Proline and gamma-carboxylated glutamate residues in matrix Gla protein are critical for binding of bone morphogenetic protein-4. (2008). https://pubmed.ncbi.nlm.nih.gov/18369157/ DOI: 10.1161/circresaha.107.166124
- tissue_or_cell_type
- Calcium/BMP binding and differentiation
Vitamin K2: menaquinone forms, carboxylation, recycling and nutrient interactions (2026-09-17) · lines 552–563
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Site-directed mutants, calcium assays and BMP reporters · source_derived_draft · unverified_draft
### k2-mgp-bmp4 MGP Gla residues and Pro64 contributed to BMP4 binding and inhibition; only BMP4-binding-competent variants prevented osteogenic differentiation and calcification. Condition category: normal nutrient_topic: Vitamin K2 research collection; topical membership is not evidence of a direct dietary effect. plain_language: A calcium-binding protein also controls a signal that can change cell behavior. organism: MGP expression systems and calcifying vascular cells tissue_or_cell_type: Calcium/BMP binding and differentiation experimental_model: Site-directed mutants, calcium assays and BMP reporters limitations: Binding and calcification in experimental systems; systemic calcium should not be equated with a single binding-site measurement. exposure: Gla and Pro64 alterations, calcium chelation and warfarin evidence_span: {"source_cache": "artifacts/k2-research/18369157.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "34c7571f9f3a564647e458dc072113e807c277eaf5f542d6f3ab2e45f71ea5a4", "start_char": 0, "end_char": 1696, "text_sha256": "34c7571f9f3a564647e458dc072113e807c277eaf5f542d6f3ab2e45f71ea5a4"} [k2-p18369157] Proline and gamma-carboxylated glutamate residues in matrix Gla protein are critical for binding of bone morphogenetic protein-4. (2008). https://pubmed.ncbi.nlm.nih.gov/18369157/ DOI: 10.1161/circresaha.107.166124
Complete structured claim and evidenceFull-length MGP and its gamma-carboxylated domain inhibited calcium deposition in the tested vascular-cell model.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/k2-research/17848178.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d2d79c43cc8142d6dc8f1eab4ac99b05ceb01e50e5afb41f5ca75aec732cba27", "start_char": 0, "end_char": 1745, "text_sha256": "d2d79c43cc8142d6dc8f1eab4ac99b05ceb01e50e5afb41f5ca75aec732cba27"}
- experimental_model
- Human vascular-cell calcification and synthetic-peptide assays
- exposure
- Elevated calcium, warfarin, K1 and modified MGP peptides
- limitations
- Vitamin K1 intervention in cells; K2-specific efficacy and human arterial reversal were not tested.
- nutrient_topic
- Vitamin K2 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin K2 / menaquinone family
- organism
- Human vascular smooth muscle cells
- plain_language
- One vitamin K-dependent protein modification contributes to local control of mineral deposition.
- primary_references
- [k2-p17848178] Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. (2007). https://pubmed.ncbi.nlm.nih.gov/17848178/ DOI: 10.1111/j.1538-7836.2007.02758.x
- tissue_or_cell_type
- Extracellular matrix and vesicle-like surfaces
Vitamin K2: menaquinone forms, carboxylation, recycling and nutrient interactions (2026-09-17) · lines 513–524
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human vascular-cell calcification and synthetic-peptide assays · source_derived_draft · unverified_draft
### k2-mgp-gla Full-length MGP and its gamma-carboxylated domain inhibited calcium deposition in the tested vascular-cell model. Condition category: normal nutrient_topic: Vitamin K2 research collection; topical membership is not evidence of a direct dietary effect. plain_language: One vitamin K-dependent protein modification contributes to local control of mineral deposition. organism: Human vascular smooth muscle cells tissue_or_cell_type: Extracellular matrix and vesicle-like surfaces experimental_model: Human vascular-cell calcification and synthetic-peptide assays limitations: Vitamin K1 intervention in cells; K2-specific efficacy and human arterial reversal were not tested. exposure: Elevated calcium, warfarin, K1 and modified MGP peptides evidence_span: {"source_cache": "artifacts/k2-research/17848178.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d2d79c43cc8142d6dc8f1eab4ac99b05ceb01e50e5afb41f5ca75aec732cba27", "start_char": 0, "end_char": 1745, "text_sha256": "d2d79c43cc8142d6dc8f1eab4ac99b05ceb01e50e5afb41f5ca75aec732cba27"} [k2-p17848178] Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. (2007). https://pubmed.ncbi.nlm.nih.gov/17848178/ DOI: 10.1111/j.1538-7836.2007.02758.x
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.